Mechanistically, EVs released by EBV-positive NPC activate the ERK and phosphatidylinositol 3 kinase (PI3K) / AKT proliferation pathways in cancer and endothelial cells via selective transport of LMP1, EGFR, and virus-encoded miRNAs [61, 62]. Here, AKT1 is linked to cancer.